Objectives: Community-genotype methicillin-resistant Staphylococcus aureus (MRSA) clones have emerged in the community worldwide and recently have been spreading into the hospitals. To identify predictors of sequence type 72-MRSA-SCCmec type IV (ST72-MRSA-IV) in patients with community-onset (CO) S. aureus infection, a case-control study was conducted among CO S. aureus infections, including healthcareassociated infections.
Introduction
During the past decade, community-associated methicillinresistant Staphylococcus aureus (CA-MRSA) infections have emerged with varying prevalence and geographical differences in strains. 1, 2 The adverse outcomes of community-onset (CO) infections caused by CA-MRSA have aroused many concerns. It is important to identify the risk factors of CA-MRSA infections among CO S. aureus infections, to enable appropriate initial empirical antimicrobial therapy. However, previous studies have mostly used the epidemiological definition for CA-MRSA, 1 which limits their applicability because many community-genotype MRSA infections with healthcareassociated (HCA) risk factors were excluded in those studies. Although CA-MRSA strains originated within the community, they are now being observed frequently in healthcare settings and can cause CO HCA infections as well as nosocomial infections. 2 Sequence type 72-MRSA-SCCmec type IV (ST72-MRSA-IV) strains have been established as a representative CA-MRSA clone in Korea. 2, 3 In order to identify clinical predictors of the ST72-MRSA-IV infections among CO S. aureus infections, we designed a case-control study comparing clinical characteristics between patients with CO ST72-MRSA-IV infections and those with methicillin-susceptible S. aureus (MSSA) infections.
Patients and methods

Study design, patient selection and data collection
This was a matched case-control study conducted in a 1900 bed tertiary-care university hospital (Samsung Medical Center, Seoul, Korea) Among 4667 MRSA isolates from 3417 patients, 452 isolates susceptible to fluoroquinolone, gentamicin, rifampicin and sulfamethoxazole/trimethoprim were selected to screen for ST72-MRSA-IV. ST72-MRSA-IV infections were verified in 124 patients. 4 Finally, 84 cases of CO infections were defined as the cases. To select the controls, we screened the patients with CO infections caused by MSSA during the same period. Each case was matched to a control by the date of admission in a 1: 1 ratio. The demographic and clinical information was collected by reviewing electronic medical records. This study was approved by the Institute Review Board of Samsung Medical Center.
Definitions
CO S. aureus infection was defined as an infection occurring in the community or up to 48 h after admission. HCA infections were defined based on the fulfilment of any of the following criteria: hospitalization or surgery within the year preceding admission; residence in a long-term care facility; receipt of home infusion therapy or home wound care; dialysis; and catheterization within the 30 days before admission. 5 Skin and soft tissue infection (SSTI) was defined as an infection limited to skin and soft tissue, and was further classified into complicated or uncomplicated. Cases of necrotizing infection, pyomyositis, surgical site infection (SSI) and diabetic foot infection were classified as complicated, while uncomplicated SSTI included cellulitis, erysipelas and simple abscesses. SSI was defined as SSTI of the incision site occurring within 30 days after the surgery. Appropriate antimicrobial therapy was defined as initial empirical antimicrobials given during the first 48-72 h after the onset of infection that were active against MRSA.
Microbiological identification, antimicrobial susceptibility testing and molecular characterization
The Vitek 2 automated system (bioMérieux, Marcy l'Étoile, France) was used for microbiological identification and antimicrobial susceptibility testing using a standard identification card and the modified broth microdilution method. The MICs were determined according to the standards established by the CLSI. 6 The methods for the determination of the SCCmec type and sequence type were as described previously.
2,4
Statistical analysis A stepwise backward multivariate logistic regression analysis model was used. Variables with a P value ,0.1 in the univariate analyses were candidates for inclusion in the multivariate analysis and variables for which the P value was ,0.05 in the multivariate analysis were retained in the final model. OR and their 95% CI were calculated. All P values were twotailed and P values ,0.05 were considered statistically significant. SPSS for Windows, PASW version 18.0 (SPSS Inc., Chicago, IL, USA) was used for analysis.
Results
Univariate comparisons of clinical characteristics and outcomes of CO infections between ST72-MRSA-IV and MSSA
Female sex was more frequent in ST72-MRSA-IV infections than in MSSA infections (58.3% versus 39.3%) ( Table 1) . Any kind of underlying disease, in particular solid tumour, was more frequent in ST72-MRSA-IV infections than in MSSA infections. The ST72-MRSA-IV group more frequently presented with severe sepsis or septic shock than did the MSSA group (19.0% versus 8.3%, P ¼0.043). The patients with ST72-MRSA-IV infections had higher rates of HCA risk factors compared with those in the control group. Especially, prior hospitalization and surgery within the preceding year were associated with ST72-MRSA-IV infections.
The most common type of infection was SSTI in both groups, which accounted for 48.8% and 52.4% of infections, respectively (Table 1) . Among SSTI, SSI was more frequent in ST72-MRSA-IV infections than in MSSA infections (17.9% versus 4.8%, P ¼ 0.007). SSI caused by ST72-MRSA-IV included infections occurring at a sternal wound (three cases), mastectomy wound (three cases), abdominal incision wound (three cases), craniectomy wound (two cases), myomectomy wound (two cases), head and neck wound (one case), and extremities (one case). The patients with ST72-MRSA-IV infections were less likely to receive appropriate empirical antibacterial therapy than those with MSSA infections (38.1% versus 96.4%, P,0.001) ( Table 1) . Any significant differences in in-hospital mortality and length of hospital stay were not found between the two groups.
In vitro antimicrobial susceptibility of S. aureus isolates
The susceptibility rates of ST72-MRSA-IV isolates to clindamycin, erythromycin and fusidic acid were compared with those for MSSA. The susceptibility rates to clindamycin and erythromycin in ST72-MRSA-IV isolates were lower than those in MSSA (75.0% versus 99.3%, P ¼0.016; 57.1% versus 80.0%, P ¼0.002, respectively), whereas the susceptibility rate to fusidic acid in ST72-MRSA-IV was higher (97.6% versus 78.6%, P,0.001, respectively).
Independent predictors of ST72-MRSA-IV versus MSSA infection among CO S. aureus infection
In order to identify independent predictors of ST72-MRSA-IV infections among patients with CO S. aureus infections, multivariate analyses were performed. Female sex (OR 2.55, 95% CI 1.30-5.04), severe sepsis or septic shock (OR 3.05, 95% CI 1.09-8.55), prior hospitalization within the previous year (OR 2.18, 95% CI 1.10 -4.32) and SSI (OR 4.63, 95% CI 1.38-15.59) were independently associated with ST72-MRSA-IV infections ( Table 2 ).
Discussion
In this study, we identified clinical predictors of infections caused by ST72-MRSA-IV, which is a CA-MRSA epidemic clone in Korea, among patients with CO S. aureus infections as compared with CO-MSSA infections. Female sex, SSI, presentation with severe sepsis or septic shock and prior hospitalization within the previous year were independent predictors of ST72-MRSA-IV infections. This is the first study that has identified clinical predictors of a community-genotype MRSA among CO S. aureus infections in Korea. Previous studies in the USA have described the risk factors for CA-MRSA infections as neonates, children beyond the neonatal period, athletes, household contacts of MRSA SSTI patients, detainees in jail or prison, military personnel, Joo et al. 7 In fact, the risk factors of CA-MRSA vary with the strain, the study population and many other factors. In European countries where CA-MRSA is not endemic, patients of non-European origin have been reported to be an important risk factor for CA-MRSA infections. 8, 9 Earlier studies to identify predictors for CA-MRSA infections have focused on epidemiologically defined CA-MRSA without any known HCA risk factors. 1 However, various CA-MRSA clones have emerged as being important in the aetiology of HCA infections in many regions. 2 In our study, we therefore defined CO infections caused by ST72-MRSA-IV as the case, regardless of the presence of HCA risk factors. Interestingly, HCA risk factors were found to be more frequent in patients with ST72-MRSA-IV infections compared with those with MSSA infections, and SSI was more frequently observed in those with ST72-MRSA-IV infections. The finding that SSI included infections in mastectomy and myomectomy wounds probably reflects the predominance of female sex in patients with ST72-MRSA-IV infections. All these indicate that a community-genotype MRSA clone emerging in Korea has already become important in the aetiology of HCA infections, especially SSI. An increase in SSIs caused by community-genotype MRSA would be of great concern, because cefazolin, which is one of the most frequently recommended antibiotics for surgical prophylaxis, cannot prevent them.
There are some limitations to our study. First, this was a retrospective study based on medical records and so potential information bias might have affected the results. Second, since this study was performed at a large tertiary-care hospital, data from this study may not be able to reflect the national status. Third, antibiotic susceptibility patterns were used for the screening of community-genotype strains based on previous reports from Korea.
10 ST72-MRSA-IV strains were reported to be resistant to erythromycin and clindamycin (96%), with 30% -40% resistance to fluoroquinolone and gentamicin, and ,10% resistance to rifampicin and sulfamethoxazole/trimethoprim. 10 Therefore, a substantial proportion of ST72-MRSA-IV strains that are resistant to fluoroquinolone and gentamicin could have been excluded from the analysis. Lastly, this study was performed in a PantonValentine leucocidin (PVL)-negative ST72-MRSA-IV and the results cannot be generalized to other CA-MRSA clones.
In conclusion, female sex, SSI, severe sepsis or septic shock and prior hospitalization within the previous year were independent predictors for ST72-MRSA-IV among patients with CO S. aureus infections.
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